These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22214700)

  • 1. Chronic pharmacological preconditioning against ischemia.
    Luca MC; Liuni A; Muxel S; Münzel T; Forconi S; Gori T; Parker JD
    Clin Hemorheol Microcirc; 2011; 49(1-4):287-93. PubMed ID: 22214700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus mitigates cardioprotective effects of remifentanil preconditioning in ischemia-reperfused rat heart in association with anti-apoptotic pathways of survival.
    Kim HS; Cho JE; Hwang KC; Shim YH; Lee JH; Kwak YL
    Eur J Pharmacol; 2010 Feb; 628(1-3):132-9. PubMed ID: 19944681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial protection at a crossroads: the need for translation into clinical therapy.
    Bolli R; Becker L; Gross G; Mentzer R; Balshaw D; Lathrop DA;
    Circ Res; 2004 Jul; 95(2):125-34. PubMed ID: 15271864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of mitogen-activated protein kinases in ischemic and nitroglycerin-induced preconditioning.
    Iliodromitis EK; Gaitanaki C; Lazou A; Aggeli IK; Gizas V; Bofilis E; Zoga A; Beis I; Kremastinos DT
    Basic Res Cardiol; 2006 Jul; 101(4):327-35. PubMed ID: 16612556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.
    Eckle T; Krahn T; Grenz A; Köhler D; Mittelbronn M; Ledent C; Jacobson MA; Osswald H; Thompson LF; Unertl K; Eltzschig HK
    Circulation; 2007 Mar; 115(12):1581-90. PubMed ID: 17353435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healing the diabetic heart: does myocardial preconditioning work?
    Balakumar P; Sharma NK
    Cell Signal; 2012 Jan; 24(1):53-9. PubMed ID: 21945408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconditioning and postconditioning: new strategies for cardioprotection.
    Hausenloy DJ; Yellon DM
    Diabetes Obes Metab; 2008 Jun; 10(6):451-9. PubMed ID: 17825079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiology and pharmacology of myocardial preconditioning and postconditioning.
    Huffmyer J; Raphael J
    Semin Cardiothorac Vasc Anesth; 2009 Mar; 13(1):5-18. PubMed ID: 19329471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing infarct size in the setting of acute myocardial infarction.
    Downey JM; Cohen MV
    Prog Cardiovasc Dis; 2006; 48(5):363-71. PubMed ID: 16627050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning, postconditioning and their application to clinical cardiology.
    Kloner RA; Rezkalla SH
    Cardiovasc Res; 2006 May; 70(2):297-307. PubMed ID: 16516180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ischemic preconditioning of the heart].
    Eisen A; Schwammenthal E; Adler Y
    Harefuah; 2008 Feb; 147(2):163-8, 181. PubMed ID: 18357677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
    Shi EY; Jiang XJ; Bai H; Nakajima Y
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 5 different remifentanil strategies against myocardial ischemia-reperfusion injury.
    Chun KJ; Park YH; Kim JS; Jang Y; Kim JH; Kim J; Lee MY
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):926-30. PubMed ID: 21514843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
    Salloum F; Yin C; Xi L; Kukreja RC
    Circ Res; 2003 Apr; 92(6):595-7. PubMed ID: 12637371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preconditioning the hyperlipidemic myocardium: fact or fantasy?
    Balakumar P; Babbar L
    Cell Signal; 2012 Mar; 24(3):589-95. PubMed ID: 22101013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different preconditioning stimuli invoke disparate electromechanical and energetic responses to global ischemia in rat hearts.
    Rehring TF; Bender PR; Cairns CB; Joo K; Friese RS; Shapiro JI; Cleveland JC; Banerjee A
    Can J Physiol Pharmacol; 1997 Apr; 75(4):335-42. PubMed ID: 9196860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats.
    Li R; Wong GT; Wong TM; Zhang Y; Xia Z; Irwin MG
    Anesth Analg; 2009 Jan; 108(1):23-9. PubMed ID: 19095826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nitric oxide and myocardial ischemic preconditioning].
    Ghaleh B; Tissier R; Berdeaux A
    J Soc Biol; 2000; 194(3-4):137-41. PubMed ID: 11324315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.